🔎 Trials Near Me

Akèy › Myelofibroz › Tennessee › Nashville

Etid klinik pou Myelofibroz nan Nashville, TN

9 etid pou Myelofibroz ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Ap rekriteFaz 1/2
  • Tri-Star Centennial Medical Center, Nashville
  • Vanderbilt University, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04176198

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Ap rekriteFaz 3
  • Vanderbilt-Ingram Cancer Center (VICC)-Nashville, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07623161

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Tennessee Oncology, PLLC - Investigational Drug Services, Nashville
  • Tristar BMT, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07469891

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Ap rekriteFaz 2
  • Vanderbilt University/Ingram Cancer Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06661915

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Tristar Bmt/Tcto, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07441694

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

Ap rekriteFaz 2
  • GSK Investigational Site, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT06517875

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Nashville
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Ap rekriteFaz 3
  • Tennessee Oncology, Nashville
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2025 · NCT06479135

Etid Myelofibroz nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.